Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cold agglutinin anti-I antibodies in two patients with COVID-19.
Imoto H, Yoshioka S, Nakagawa D, Hasegawa K, Kuroda H, Hasuike T, Doi A, Kusumoto T, Ishikawa T. Imoto H, et al. J Clin Lab Anal. 2022 Sep;36(9):e24629. doi: 10.1002/jcla.24629. Epub 2022 Aug 2. J Clin Lab Anal. 2022. PMID: 35917437 Free PMC article.
Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT.
Matsui H, Arai Y, Imoto H, Mitsuyoshi T, Tamura N, Kondo T, Kanda J, Ishikawa T, Imada K, Ueda Y, Toda Y, Anzai N, Yago K, Nohgawa M, Yonezawa A, Tsunemine H, Itoh M, Yamamoto K, Tsuji M, Moriguchi T, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group (KSCTG). Matsui H, et al. Among authors: imoto h. Blood Adv. 2020 Jul 14;4(13):3169-3179. doi: 10.1182/bloodadvances.2020002007. Blood Adv. 2020. PMID: 32658984 Free PMC article.
Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in patients with haematological diseases treated with anti-CD20 antibodies: An observational study.
Nishikubo M, Shimomura Y, Maruoka H, Nasu S, Nishioka T, Sakizono K, Mitsuyuki S, Kubo T, Okada N, Nakagawa D, Kamijo K, Imoto H, Yamamoto R, Nagai Y, Hiramoto N, Yoshioka S, Yonetani N, Matsushita A, Miyakoshi C, Doi A, Ishikawa T. Nishikubo M, et al. Among authors: imoto h. Br J Haematol. 2022 Jun;197(6):709-713. doi: 10.1111/bjh.18151. Epub 2022 Mar 20. Br J Haematol. 2022. PMID: 35262920 Free PMC article. No abstract available.
Elderly-onset systemic Epstein-Barr virus-positive T-cell lymphoma of childhood.
Nishikubo M, Hiramoto N, Yamashita D, Imoto H, Sato Y, Okuno Y, Haga H, Nannya Y, Ogawa S, Kimura H, Ishikawa T. Nishikubo M, et al. Among authors: imoto h. Pathol Int. 2022 Jul;72(7):376-378. doi: 10.1111/pin.13231. Epub 2022 May 24. Pathol Int. 2022. PMID: 35611496 Free PMC article. No abstract available.
Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study.
Nishikubo M, Shimomura Y, Maruoka H, Nasu S, Nishioka T, Sakizono K, Mitsuyuki S, Kubo T, Okada N, Nakagawa D, Kamijo K, Imoto H, Yamamoto R, Nagai Y, Hiramoto N, Yoshioka S, Yonetani N, Matsushita A, Miyakoshi C, Doi A, Ishikawa T. Nishikubo M, et al. Among authors: imoto h. J Infect Chemother. 2023 Mar;29(3):274-280. doi: 10.1016/j.jiac.2022.11.010. Epub 2022 Nov 26. J Infect Chemother. 2023. PMID: 36442827 Free PMC article.
Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies.
Nishikubo M, Shimomura Y, Yamamoto R, Yoshioka S, Maruoka H, Nasu S, Nishioka T, Sakizono K, Mitsuyuki S, Kubo T, Okada N, Nakagawa D, Kamijo K, Imoto H, Nagai Y, Hiramoto N, Yonetani N, Kondo T, Miyakoshi C, Doi A, Ishikawa T. Nishikubo M, et al. Among authors: imoto h. Blood Cancer J. 2023 Jan 23;13(1):17. doi: 10.1038/s41408-023-00792-z. Blood Cancer J. 2023. PMID: 36690628 Free PMC article. No abstract available.
214 results